181 related articles for article (PubMed ID: 36755960)
1. Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatment.
Koeniger A; Polo P; Brichkina A; Finkernagel F; Visekruna A; Nist A; Stiewe T; Daude M; Diederich WE; Gress TM; Adhikary T; Lauth M
NAR Cancer; 2023 Mar; 5(1):zcad007. PubMed ID: 36755960
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the developmental origin of neuroblastoma: an overview.
Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P
J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192
[TBL] [Abstract][Full Text] [Related]
3. Deep analysis of neuroblastoma core regulatory circuitries using online databases and integrated bioinformatics shows their pan-cancer roles as prognostic predictors.
Jahangiri L; Pucci P; Ishola T; Pereira J; Cavanagh ML; Turner SD
Discov Oncol; 2021 Nov; 12(1):56. PubMed ID: 35201514
[TBL] [Abstract][Full Text] [Related]
4. A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.
van Groningen T; Akogul N; Westerhout EM; Chan A; Hasselt NE; Zwijnenburg DA; Broekmans M; Stroeken P; Haneveld F; Hooijer GKJ; Savci-Heijink CD; Lakeman A; Volckmann R; van Sluis P; Valentijn LJ; Koster J; Versteeg R; van Nes J
Nat Commun; 2019 Apr; 10(1):1530. PubMed ID: 30948783
[TBL] [Abstract][Full Text] [Related]
5. Super-enhancer associated core regulatory circuits mediate susceptibility to retinoic acid in neuroblastoma cells.
Gomez RL; Woods LM; Ramachandran R; Abou Tayoun AN; Philpott A; Ali FR
Front Cell Dev Biol; 2022; 10():943924. PubMed ID: 36147741
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.
Westerhout EM; Hamdi M; Stroeken P; Nowakowska NE; Lakeman A; van Arkel J; Hasselt NE; Bleijlevens B; Akogul N; Haneveld F; Chan A; van Sluis P; Zwijnenburg D; Volckmann R; van Noesel CJM; Adameyko I; van Groningen T; Koster J; Valentijn LJ; van Nes J; Versteeg R
Cancer Res; 2022 Feb; 82(3):484-496. PubMed ID: 34853072
[TBL] [Abstract][Full Text] [Related]
7. ASCL1 characterizes adrenergic neuroblastoma via its pioneer function and cooperation with core regulatory circuit factors.
Wang L; Tan TK; Kim H; Kappei D; Tan SH; Look AT; Sanda T
Cell Rep; 2023 Dec; 42(12):113541. PubMed ID: 38060444
[TBL] [Abstract][Full Text] [Related]
8. Combination of tumor necrosis factor-α and epidermal growth factor induces the adrenergic-to-mesenchymal transdifferentiation in SH-SY5Y neuroblastoma cells.
Huang Y; Tsubota S; Nishio N; Takahashi Y; Kadomatsu K
Cancer Sci; 2021 Feb; 112(2):715-724. PubMed ID: 33277754
[TBL] [Abstract][Full Text] [Related]
9. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
10. T-cell inflammation is prognostic of survival in patients with high-risk neuroblastoma enriched for an adrenergic signature.
Kaufman ME; Vayani OR; Moore K; Chlenski A; Wu T; Chavez G; Lee SM; Desai AV; He C; Cohn SL; Applebaum MA
bioRxiv; 2023 Jun; ():. PubMed ID: 37425883
[TBL] [Abstract][Full Text] [Related]
11. Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation.
Chen YL; Zhuo R; Sun LC; Tao YF; Li G; Zhu F; Xu YY; Wang JW; Li ZH; Yu JJ; Yin HL; Wu D; Li XL; Fang F; Xie Y; Hu YZ; Wang HR; Yang C; Shi L; Wang XD; Zhang ZM; Pan J
Neuro Oncol; 2024 Jun; ():. PubMed ID: 38864832
[TBL] [Abstract][Full Text] [Related]
12. Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
Vayani OR; Kaufman ME; Moore K; Chennakesavalu M; TerHaar R; Chaves G; Chlenski A; He C; Cohn SL; Applebaum MA
Pediatr Blood Cancer; 2024 Jan; 71(1):e30735. PubMed ID: 37859597
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal impacts of telomerase activity and ADRN/MES differentiation state in neuroblastoma tumor biology.
Yu EY; Zahid SS; Aloe S; Falck-Pedersen E; Zhou XK; Cheung NV; Lue NF
Commun Biol; 2021 Nov; 4(1):1315. PubMed ID: 34799676
[TBL] [Abstract][Full Text] [Related]
14. Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
Vayani OR; Kaufman ME; Moore K; Chennakesavalu M; TerHaar R; Chaves G; Chlenski A; He C; Cohn SL; Applebaum MA
bioRxiv; 2023 Sep; ():. PubMed ID: 37693610
[TBL] [Abstract][Full Text] [Related]
15. Association of high-risk neuroblastoma classification based on expression profiles with differentiation and metabolism.
Kimura S; Sekiguchi M; Watanabe K; Hiwatarai M; Seki M; Yoshida K; Isobe T; Shiozawa Y; Suzuki H; Hoshino N; Hayashi Y; Oka A; Miyano S; Ogawa S; Takita J
PLoS One; 2021; 16(1):e0245526. PubMed ID: 33465163
[TBL] [Abstract][Full Text] [Related]
16. Super enhancer-driven core transcriptional regulatory circuitry crosstalk with cancer plasticity and patient mortality in triple-negative breast cancer.
Shi W; Zhong B; Dong J; Hu X; Li L
Front Genet; 2023; 14():1258862. PubMed ID: 37900187
[TBL] [Abstract][Full Text] [Related]
17. Cancer CRC: A Comprehensive Cancer Core Transcriptional Regulatory Circuit Resource and Analysis Platform.
Wei L; Chen J; Song C; Zhang Y; Zhang Y; Xu M; Feng C; Gao Y; Qian F; Wang Q; Shang D; Zhou X; Zhu J; Wang X; Jia Y; Liu J; Zhu Y; Li C
Front Oncol; 2021; 11():761700. PubMed ID: 34712617
[TBL] [Abstract][Full Text] [Related]
18. Core regulatory circuitries in defining cancer cell identity across the malignant spectrum.
Jahangiri L; Tsaprouni L; Trigg RM; Williams JA; Gkoutos GV; Turner SD; Pereira J
Open Biol; 2020 Jul; 10(7):200121. PubMed ID: 32634370
[TBL] [Abstract][Full Text] [Related]
19. Super enhancers define regulatory subtypes and cell identity in neuroblastoma.
Gartlgruber M; Sharma AK; Quintero A; Dreidax D; Jansky S; Park YG; Kreth S; Meder J; Doncevic D; Saary P; Toprak UH; Ishaque N; Afanasyeva E; Wecht E; Koster J; Versteeg R; Grünewald TGP; Jones DTW; Pfister SM; Henrich KO; van Nes J; Herrmann C; Westermann F
Nat Cancer; 2021 Jan; 2(1):114-128. PubMed ID: 35121888
[TBL] [Abstract][Full Text] [Related]
20. Enteric neural crest differentiation in ganglioneuromas implicates Hedgehog signaling in peripheral neuroblastic tumor pathogenesis.
Gershon TR; Shiraz A; Qin LX; Gerald WL; Kenney AM; Cheung NK
PLoS One; 2009 Oct; 4(10):e7491. PubMed ID: 19834598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
